Top news of the week: 07.12.2021.
Healthcare
Biotech Firm’s T-Cell Therapy Gets Positive Results in B-Cell Non-Hodgkin’s Lymphoma Study Market Gainer
Adicet Bio Inc. shares traded 37% higher after the company reported positive interim data from ADI-001 study.
ITM and Navigo Proteins Announce Research Collaboration to Develop FAP-targeting Radionuclide Therapy to Address Solid Tumors
ITM and Navigo Proteins Announce Research Collaboration to Develop FAP-targeting Radionuclide Therapy to Address Solid Tumors. Novel strategy for breaking the tumor microenvironment by ...
T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes
Engineered T cells kill leukemic cells with little off-target toxicity.
A Look Ahead at Biotech in 2022
The past two have brought a biotech boom -- and, in the Covid vaccines, incontrovertible evidence of the industry's importance. Now with both public a
Global acclaim for CUHK profs
Three Chinese University professors have been named the top 20 translational researchers of 2020 by a renowned scientific journal.They are Dennis Lo Yuk-ming, Rossa Chiu Wai-kwun and Allen ...
23andMe Announces the Appointment of Joseph R. Arron, M.D., Ph.D. as Chief Scientific Officer
Dr. Arron brings nearly two decades of scientific leadership in biotech drug discovery and development to 23andMe’s Therapeutics team SUNNYVALE, Calif., Nov. 30, 2021 (GLOBE NEWSWIRE) -- ...